Quantcast

Latest Gene therapy Stories

2014-04-08 08:32:20

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/492nrm/gene_therapy) has announced the addition of a new report "Gene Therapy - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/492nrm/gene_therapy ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Gene therapy can be broadly defined as the transfer of defined genetic material to specific target...

2014-04-08 08:32:18

DUBLIN, April 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/t2pjhw/personalized) has announced the addition of a new report "Personalized Medicine - Scientific and Commercial Aspects" [http://www.researchandmarkets.com/research/t2pjhw/personalized ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The aim of personalized medicine or individualized treatment is to match the right drug to...

2014-04-07 16:08:27

The transfer, via a viral vector, of a normal copy of the gene deficient in patients, allowed to fully and very rapidly cure the heart disease in mice. These findings are published in Nature Medicine on 6 April, 2014. Friedreich's ataxia is a severe, rare hereditary disorder which combines progressive neuro-degeneration, impaired heart function and an increased risk of diabetes. The condition affects one in every 50,000 birth. There is currently no effective treatment for this disease. In...

2014-04-07 08:32:15

Members committed to the standardization of cell therapies, regenerative medicine drugs and other biologics. LARKSPUR, Calif., April 7, 2014 /PRNewswire/ -- Today BioCision, LLC, a leader in advanced temperature management technologies that standardize biomaterial handling, announced the establishment of the company's first advisory board. Lori Kunkel, MD, former chief medical officer at Pharmacyclics, Inc., will serve as chair of the board, and will be joined by Scott Burger, MD,...

2014-04-06 16:20:26

AAVLife aimed at advancing gene therapy for cardiomyopathy in Friedreich's ataxia to clinic DOWNINGTOWN, Pa., April 6, 2014 /PRNewswire-USNewswire/ -- The Friedreich's Ataxia Research Alliance (FARA) is pleased to recognize the ground-breaking gene-therapy research of FARA-funded scientist Dr. Hélène Puccio. In the current online issue of Nature Medicine, Dr. Puccio and her colleagues present significant results demonstrating that gene-replacement therapy using an adeno-associated...

2014-04-02 11:30:25

Animal study points to promise of gene therapy for treating spinal cord injury Delivering a single injection of a scar-busting gene therapy to the spinal cord of rats following injury promotes the survival of nerve cells and improves hind limb function within weeks, according to a study published April 2 in The Journal of Neuroscience. The findings suggest that, with more confirming research in animals and humans, gene therapy may hold the potential to one day treat people with spinal cord...

2014-04-01 23:23:22

Dr. Beverly Davidson Researches Novel Treatments for Neurological Diseases Philadelphia, PA (PRWEB) April 01, 2014 Beverly L. Davidson, Ph.D., a nationally prominent expert in gene therapy, is joining The Children’s Hospital of Philadelphia (CHOP) today. Dr. Davidson, who investigates gene therapy for neurodegenerative diseases, arrives from the Center for Gene Therapy at the University of Iowa. She served as associate director at that Center, as well as director of the Gene Therapy...

2014-04-01 20:21:49

DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/pttfr4/cancer_gene) has announced the addition of the "Cancer Gene Therapy Market Analysis" [http://www.researchandmarkets.com/research/pttfr4/cancer_gene ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The gene therapy market has undergone series of transformation from the initial days of research to current clinical...

2014-03-31 20:22:11

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fl4bmp/global_cell) has announced the addition of the "Global Cell Therapy Market & Pipeline Insight" [http://www.researchandmarkets.com/research/fl4bmp/global_cell ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Research in cell therapy is transforming the future of medicine. As the life of a human being begins as...

2014-03-25 00:23:24

PHILADELPHIA, March 25, 2014 /PRNewswire/ -- Spark Therapeutics and Genable Technologies announced today that they have entered into a collaboration agreement for Genable's lead therapeutic to treat rhodopsin-linked autosomal dominant retinitis pigmentosa (RHO adRP), GT038. Under the terms of the collaboration, Genable will license certain adeno-associated virus (AAV) vector manufacturing patents from Spark. The parties have entered into a broad agreement in which Spark will be the...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related